TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
Read More
Most CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.
From site selection to protocol design, inclusive trials produce better science. TFS HealthScience on closing the representation gap.
LGBTQ+ patients want to take part in clinical research. Most are never asked. Here is what the science says and what better recruitment looks like in practice.
Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
Learn how ARVO 2026 signals a new era of precision ophthalmology, where smarter recruitment, imaging consistency and patient‑centric design demand deep‑tier partnerships like those offered by TFS.
The FDA reminded over 2,200 sponsors to submit overdue ClinicalTrials.gov results. This how TFS Medical Writing team can help.
Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Psoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.
Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Explore how sponsors can stay ahead of evolving regulatory demands, tech shifts, and enrollment pressures in today’s complex clinical trial landscape.
Discover how natural history data, external controls, and RWE are reshaping rare neurological disease trials for smarter, regulatory-ready design.
Discover how TFS is helping sponsors prepare for ICH E6(R3) with proactive oversight, modern technologies, and quality-first trial design.
From digital biomarkers to AI-enabled feasibility, explore the top trends reshaping CNS clinical trials in 2025 and how innovative CROs are helping sponsors bring neuroscience clinical research to life.
Explore a decade of progress and the critical next steps in LGBTQIA+ clinical trial inclusion.